These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8386302)

  • 21. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex for adults and adolescents infected with human immunodeficiency virus. U.S. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex.
    MMWR Recomm Rep; 1993 Jun; 42(RR-9):14-20. PubMed ID: 8393134
    [No Abstract]   [Full Text] [Related]  

  • 22. Rifabutin.
    Mofenson LM
    Pediatr Infect Dis J; 1998 Jan; 17(1):71-2. PubMed ID: 9469400
    [No Abstract]   [Full Text] [Related]  

  • 23. Corneal endothelial deposits in children positive for human immunodeficiency virus receiving rifabutin prophylaxis for Mycobacterium avium complex bacteremia.
    Arevalo JF; Freeman WR
    Am J Ophthalmol; 2000 Mar; 129(3):410-1. PubMed ID: 10755956
    [No Abstract]   [Full Text] [Related]  

  • 24. Rifabutin prophylaxis and uveitis.
    Fuller JD; Stanfield LE; Craven DE
    N Engl J Med; 1994 May; 330(18):1315-6. PubMed ID: 8145794
    [No Abstract]   [Full Text] [Related]  

  • 25. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
    Gordin FM; Sullam PM; Shafran SD; Cohn DL; Wynne B; Paxton L; Perry K; Horsburgh CR
    Clin Infect Dis; 1999 May; 28(5):1080-5. PubMed ID: 10452638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention and treatment of Mycobacterium avium complex infection.
    Mangura BT; Reichman LB
    Res Microbiol; 1994; 145(3):181-7. PubMed ID: 7809470
    [No Abstract]   [Full Text] [Related]  

  • 27. HIV: opportunistic infections.
    Ioannidis J; Wilkinson D
    Clin Evid; 2003 Jun; (9):795-816. PubMed ID: 15366175
    [No Abstract]   [Full Text] [Related]  

  • 28. Don't have a MAC attack. How to fight AIDS-related MAC. National Institutes of Health.
    AIDS Alert; 1997 Feb; 12(2):suppl 2. PubMed ID: 11364037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rifabutin prophylaxis against Mycobacterium avium complex infection.
    Zbrozek AS
    N Engl J Med; 1994 Feb; 330(6):437; author reply 438. PubMed ID: 7904329
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy of triple drug regimen of amikacin, ethambutol and rifabutin in AIDS patients with symptomatic Mycobacterium avium complex infection.
    Jorup-Rönström C; Julander I; Petrini B
    J Infect; 1993 Jan; 26(1):67-70. PubMed ID: 8384230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uveitis associated with rifabutin therapy: a clinical alert.
    Petrowski JT
    J Am Optom Assoc; 1996 Nov; 67(11):693-6. PubMed ID: 8979664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rifabutin prophylaxis against Mycobacterium avium complex infection.
    Goldschmidt RH; Hearst N; Chambers DB
    N Engl J Med; 1994 Feb; 330(6):436-7; author reply 438. PubMed ID: 7904328
    [No Abstract]   [Full Text] [Related]  

  • 33. Prophylaxis of Mycobacterium avium complex bacteremia in patients with AIDS.
    Gordin F; Masur H
    Clin Infect Dis; 1994 Apr; 18 Suppl 3():S223-6. PubMed ID: 8204774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
    Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
    J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early bactericidal activity of rifabutin versus that of placebo in treatment of disseminated Mycobacterium avium complex bacteremia in AIDS patients.
    Dautzenberg B; Castellani P; Pellegrin JL; Vittecoq D; Truffot-Pernot C; Pirotta N; Sassella D
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1722-5. PubMed ID: 8807071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corneal endothelial deposits secondary to rifabutin prophylaxis for Mycobacterium avium complex bacteraemia.
    Golchin B; McClellan K
    Br J Ophthalmol; 2003 Jun; 87(6):798-9. PubMed ID: 12770995
    [No Abstract]   [Full Text] [Related]  

  • 37. [Nontuberculous mycobacteriosis; the present status and in the future. Infection with human immunodeficiency virus (HIV) and nontuberculous mycobacteriosis].
    Mizutani S
    Kekkaku; 1998 Feb; 73(2):87-92. PubMed ID: 9545702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group.
    Dubé MP; Torriani FJ; See D; Havlir DV; Kemper CA; Leedom JM; Tilles JG; McCutchan JA; Sattler FR
    Clin Infect Dis; 1999 Jan; 28(1):136-8. PubMed ID: 10028084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Azithromycin effective in preventing MAC.
    AIDS Alert; 1996 Oct; 11(10):120. PubMed ID: 11363857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rifabutin prophylaxis against Mycobacterium avium complex infection.
    Nightingale SD
    Lancet; 1995 Jan; 345(8944):265. PubMed ID: 7823751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.